miR-186, miR-3651 and miR-494: Potential biomarkers for oral squamous cell carcinoma extracted from whole blood

Oncology Reports

Volumn 31, Issue 3, 2014, Pages 1429-1436

  Ries, Jutta ^a   Vairaktaris, Eleftherios ^b   Agaimy, Abbas ^a   Kintopp, Rita ^a   Baran, Christoph ^a   Neukam, Friedrich W ^a   Nkenke, Emeka ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Diagnosis; microRNA expression; Oral squamous cell carcinoma; Quantitative RT PCR; Whole blood

Indexed keywords

MICRORNA; MICRORNA 186; MICRORNA 3651; MICRORNA 494; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER GRADING; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOUTH SQUAMOUS CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MOUTH NEOPLASMS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84896726126     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.2983     Document Type: Article

References (45)

1. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
2. Gomes CC, de Sousa SF and Gomez RS: microRNAs: small molecules with a potential role in oral squamous cell carcinoma. Curr Pharm Des 19: 1285-1291, 2013.
3. Gomes CC and Gomez RS: MicroRNA and oral cancer: future perspectives. Oral Oncol 44: 910-914, 2008.
4. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006. (Pubitemid 44629897)
5. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005. (Pubitemid 40839735)
6. Wu BH, Xiong XP, Jia J and Zhang WF: MicroRNAs: new actors in the oral cancer scene. Oral Oncol 47: 314-319, 2011.
7. Lajer CB, Nielsen FC, Friis-Hansen L, et al: Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer 104: 830-840, 2011.
8. Scapoli L, Palmieri A, Lo Muzio L, et al: MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int J Immunopathol Pharmacol 23: 1229-1234, 2010.
9. Chang SS, Jiang WW, Smith I, et al: MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 123: 2791-2797, 2008.
10. Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007. (Pubitemid 46096921)
11. Soga D, Yoshiba S, Shiogama S, et al: microRNA expression profiles in oral squamous cell carcinoma. Oncol Rep 30: 579-583, 2013.
12. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
13. Chen X, Ba Y, Ma L, et al: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006, 2008.
14. Häusler SF, Keller A, Chandran PA, et al: Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer 103: 693-700, 2010.
15. Heegaard NH, Schetter AJ, Welsh JA, et al: Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int J Cancer 130: 1378-1386, 2012.
16. Kosaka N, Iguchi H and Ochiya T: Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 101: 2087-2092, 2010.
17. Lin SC, Liu CJ, Lin JA, et al: miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncol 46: 204-208, 2010.
18. Liu CJ, Kao SY, Tu HF, et al: Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis 16: 360-364, 2010.
19. Maclellan SA, Lawson J, Baik J, et al: Differential expression of miRNAs in the serum of patients with high-risk oral lesions. Cancer Med 1: 268-274, 2012.
20. Wong TS, Liu XB, Wong BY, et al: Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 14: 2588-2592, 2008.
21. Wittmann J and Jäck HM: Serum microRNAs as powerful cancer biomarkers. Biochim Biophys Acta 1806: 200-207, 2010.
22. Liu CJ, Lin SC, Yang CC, et al: Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head Neck 34: 219-224, 2012.
23. Yang CC, Hung PS, Wang PW, et al: miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma. J Oral Pathol Med 40: 397-404, 2011.
24. Kosaka N, Iguchi H, Yoshioka Y, et al: Competitive interactions of cancer cells and normal cells via secretory microRNAs. J Biol Chem 287: 1397-1405, 2012.
25. Heneghan HM, Miller N, Lowery AJ, et al: Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251: 499-505, 2010.
26. Patel SG and Shah JP: TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 55: 242-258, 2005. (Pubitemid 41271230)
27. Benjamini Y, Drai D, Elmer G, et al: Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279-284, 2001. (Pubitemid 33000466)
28. Fluss R, Faraggi D and Reiser B: Estimation of the Youden Index and its associated cutoff point. Biom J 47: 458-472, 2005. (Pubitemid 41229379)
29. Gorenchtein M, Poh CF, Saini R and Garnis C: MicroRNAs in an oral cancer context - from basic biology to clinical utility. J Dent Res 91: 440-446, 2012.
30. Li H, Yin C, Zhang B, et al: PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186. Carcinogenesis 34: 2145-2155, 2013.
31. Zhao BS, Liu SG, Wang TY, et al: Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses. Asian Pac J Cancer Prev 14: 139-143, 2013.
32. Cai J, Wu J, Zhang H, et al: miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. Cancer Res 73: 756-766, 2013.
33. Kim SY, Lee YH and Bae YS: MiR-186, miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular senescence by targeting alpha subunit of protein kinase CKII in human colorectal cancer cells. Biochem Biophys Res Commun 429: 173-179, 2012.
34. Myatt SS, Wang J, Monteiro LJ, et al: Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res 70: 367-377, 2010.
35. Diakos C, Zhong S, Xiao Y, et al: TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a. Blood 116: 4885-4893, 2010.
36. Yamanaka S, Campbell NR, An F, et al: Coordinated effects of microRNA-494 induce G2/M arrest in human cholangiocarcinoma. Cell Cycle 11: 2729-2738, 2012.
37. Ohdaira H, Sekiguchi M, Miyata K and Yoshida K: MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells. Cell Prolif 45: 32-38, 2012.
38. Duttagupta R, Jiang R, Gollub J, et al: Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One 6: e20769, 2011.
39. Heneghan HM, Miller N and Kerin MJ: Circulating microRNAs: promising breast cancer biomarkers. Breast Cancer Res 13: 402-403, 2011.
40. Friedman EB, Shang S, de Miera EV, et al: Serum microRNAs as biomarkers for recurrence in melanoma. J Transl Med 10: 155, 2012.
41. Schwarzenbach H, Hoon DS and Pantel K: Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11: 426-437, 2011.
42. Zen K and Zhang CY: Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev 32: 326-348, 2012.
43. Osaki M, Takeshita F and Ochiya T: MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers 13: 658-670, 2008.
44. Tong AW and Nemunaitis J: Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther 15: 341-355, 2008. (Pubitemid 351693228)
45. Zhang B and Farwell MA: microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med 12: 3-21, 2008.